PortfoliosLab logo
FMS vs. DVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between FMS and DVA is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

FMS vs. DVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fresenius Medical Care AG & Co. KGaA (FMS) and DaVita Inc. (DVA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

FMS:

1.18

DVA:

0.16

Sortino Ratio

FMS:

1.97

DVA:

0.46

Omega Ratio

FMS:

1.25

DVA:

1.07

Calmar Ratio

FMS:

0.63

DVA:

0.26

Martin Ratio

FMS:

5.48

DVA:

0.64

Ulcer Index

FMS:

7.28%

DVA:

9.85%

Daily Std Dev

FMS:

28.49%

DVA:

31.45%

Max Drawdown

FMS:

-77.28%

DVA:

-92.91%

Current Drawdown

FMS:

-43.46%

DVA:

-18.56%

Fundamentals

Market Cap

FMS:

$16.66B

DVA:

$11.05B

EPS

FMS:

$1.19

DVA:

$10.73

PE Ratio

FMS:

23.86

DVA:

13.40

PEG Ratio

FMS:

0.98

DVA:

1.98

PS Ratio

FMS:

0.85

DVA:

0.86

PB Ratio

FMS:

1.02

DVA:

91.36

Total Revenue (TTM)

FMS:

$19.49B

DVA:

$9.74B

Gross Profit (TTM)

FMS:

$4.77B

DVA:

$3.05B

EBITDA (TTM)

FMS:

$1.86B

DVA:

$2.12B

Returns By Period

In the year-to-date period, FMS achieves a 24.16% return, which is significantly higher than DVA's -3.42% return. Over the past 10 years, FMS has underperformed DVA with an annualized return of -2.58%, while DVA has yielded a comparatively higher 5.91% annualized return.


FMS

YTD

24.16%

1M

17.22%

6M

31.42%

1Y

33.19%

5Y*

-4.21%

10Y*

-2.58%

DVA

YTD

-3.42%

1M

-7.12%

6M

-6.51%

1Y

5.02%

5Y*

12.88%

10Y*

5.91%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FMS vs. DVA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FMS
The Risk-Adjusted Performance Rank of FMS is 8484
Overall Rank
The Sharpe Ratio Rank of FMS is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of FMS is 8686
Sortino Ratio Rank
The Omega Ratio Rank of FMS is 8484
Omega Ratio Rank
The Calmar Ratio Rank of FMS is 7575
Calmar Ratio Rank
The Martin Ratio Rank of FMS is 8888
Martin Ratio Rank

DVA
The Risk-Adjusted Performance Rank of DVA is 5656
Overall Rank
The Sharpe Ratio Rank of DVA is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of DVA is 5050
Sortino Ratio Rank
The Omega Ratio Rank of DVA is 5151
Omega Ratio Rank
The Calmar Ratio Rank of DVA is 6363
Calmar Ratio Rank
The Martin Ratio Rank of DVA is 5858
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FMS vs. DVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fresenius Medical Care AG & Co. KGaA (FMS) and DaVita Inc. (DVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current FMS Sharpe Ratio is 1.18, which is higher than the DVA Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of FMS and DVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

FMS vs. DVA - Dividend Comparison

FMS's dividend yield for the trailing twelve months is around 2.26%, while DVA has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
FMS
Fresenius Medical Care AG & Co. KGaA
2.26%2.80%2.97%4.34%2.57%1.70%1.78%1.95%0.98%1.04%1.05%1.44%
DVA
DaVita Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

FMS vs. DVA - Drawdown Comparison

The maximum FMS drawdown since its inception was -77.28%, smaller than the maximum DVA drawdown of -92.91%. Use the drawdown chart below to compare losses from any high point for FMS and DVA. For additional features, visit the drawdowns tool.


Loading data...

Volatility

FMS vs. DVA - Volatility Comparison

Fresenius Medical Care AG & Co. KGaA (FMS) has a higher volatility of 10.49% compared to DaVita Inc. (DVA) at 8.41%. This indicates that FMS's price experiences larger fluctuations and is considered to be riskier than DVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

FMS vs. DVA - Financials Comparison

This section allows you to compare key financial metrics between Fresenius Medical Care AG & Co. KGaA and DaVita Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


3.00B3.50B4.00B4.50B5.00B20212022202320242025
4.88B
3.29B
(FMS) Total Revenue
(DVA) Total Revenue
Values in USD except per share items

FMS vs. DVA - Profitability Comparison

The chart below illustrates the profitability comparison between Fresenius Medical Care AG & Co. KGaA and DaVita Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

24.0%26.0%28.0%30.0%32.0%34.0%20212022202320242025
24.3%
32.5%
(FMS) Gross Margin
(DVA) Gross Margin
FMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Fresenius Medical Care AG & Co. KGaA reported a gross profit of 1.18B and revenue of 4.88B. Therefore, the gross margin over that period was 24.3%.

DVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DaVita Inc. reported a gross profit of 1.07B and revenue of 3.29B. Therefore, the gross margin over that period was 32.5%.

FMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Fresenius Medical Care AG & Co. KGaA reported an operating income of 381.73M and revenue of 4.88B, resulting in an operating margin of 7.8%.

DVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DaVita Inc. reported an operating income of 565.36M and revenue of 3.29B, resulting in an operating margin of 17.2%.

FMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Fresenius Medical Care AG & Co. KGaA reported a net income of 151.22M and revenue of 4.88B, resulting in a net margin of 3.1%.

DVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DaVita Inc. reported a net income of 259.33M and revenue of 3.29B, resulting in a net margin of 7.9%.